Faecal Transplantation Works for C. difficile Colitis
I have written a number of times about the role of faecal transplantation in the established intervention for Clostridium difficile and have hinted at the possible cross mechanism benefits of inducing commensal bacteria that favour tolerance into the gastrointestinal tract. The implication being, that individuals experiencing illness driven by loss of immunological tolerance, not simply within the digestive tract, but systemically may benefit from an evolutionary transplant.
Whilst there are practical considerations – there has been one small study on home administration and numerous anecdotal discussions regarding its use in a wide range of illnesses, for which a recovery has been confirmed.
A recent study ( March 2012) published in the journal Gastroenterology is one of the largest exploring Clostridium difficile patients and their outcomes following faecal transplantation.
Patients who suffer from protracted Clostridium difficile colitis despite receiving oral antibiotic therapy, often for months, have become a challenge for physicians all over the world.
The investigators reviewed data from 70 adults (mean age, 73; 86% outpatients) who had received up to 12 courses of antibiotics for CDI; most had received 3 to 6 courses. Most stool donors were close relatives of the patient. Transplantations were performed using a uniform protocol, which involved bowel preparation with an oral polyethylene glycol solution, followed by an infusion of stool into the caecum via colonoscope.
Three months after transplantation, 66 of the 70 patients reported complete resolution of symptoms. The four who did not respond all had the virulent 027 strain of C. difficile as well as other serious medical illnesses; all died within 3 months of transplantation. In the year following transplantation, four additional patients relapsed; two were treated successfully with antibiotics, and two received another faecal transplant. No complications of transplantation were reported.
No other C. difficile treatment achieves anything like the 94% eradication rate reported in this study, even in patients with relatively mild disease. Faecal transplantation would probably become the gold-standard treatment for CDI if the logistics of arranging it were not so daunting.
However, the discomfiture displayed by the physician is less of a problem for the ill patient – once the concept is fully understood and the application standardised – in as much as there is a preferred in hospital or at home methodology and pre transplant prep, then this therapy will be used more and more saving lives, money and families from unwanted misery and even death. Physician driven exclusion based on the ‘yuck’ factor is a poor and emotive based reason to avoid a compellingly safe and effective treatment.
 Silverman MS, Davis I, Pillai DR. Success of self-administered home fecal transplantation for chronic Clostridium difficile infection. Clin Gastroenterol Hepatol. 2010 May;8(5):471-3. Epub 2010 Feb 1. View Abstract
 Mattila E, Uusitalo-Seppälä R, Wuorela M, Lehtola L, Nurmi H, Ristikankare M, Moilanen V, Salminen K, Seppälä M, Mattila PS, Anttila VJ, Arkkila P. Fecal transplantation, through colonoscopy, is effective therapy for recurrent Clostridium difficile infection. Gastroenterology. 2012 Mar;142(3):490-6. Epub 2011 Dec 7. View Abstract
- Faecal Transplant by Enema Works for Stubborn C. Difficile.
- Parkinsons and Faecal Transplantation – or at least resolution of constipation!
- Pass the POO/Medicine
- Phosphatidylcholine (PC) Controls Inflammation in Ulcerative Colitis
- Whats New in The Understanding Of The Immunology Of Ulcerative Colitis?
7 Responses to “Faecal Transplantation Works for C. difficile Colitis”
Leave a Reply
28th March 2015
This one day event is designed to explore some of the clinically relevant evolving events in microbiology, mucosal immunity and functional medicine as it relates to inflammation and health. The presenters are well known for their many years of work in research, analysis, practice and lecturing. They will present substantive evidence of these evolving trends and how they impact on clinical decisions, describing where evidence is preliminary, novel, or of greater substantiation. The day will have a strong clinical bias and provide a welcome opportunity for questions and answers.Click for further information
- Background Probiotics may improve a person̵...
- The relationships between magnesium deficiency ...
- Summary review by Antony Haynes BA, RNT, promot...
- This one day event is designed to explore some ...
- In a remarkable research Paper published in the...
Updates on your email
Don't miss out on our email updates